Bullfrog AI (NASDAQ:BFRG) and Movano (NASDAQ:MOVE) Critical Analysis

Bullfrog AI (NASDAQ:BFRG) and Movano (NASDAQ:MOVE) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.

Institutional & Insider Ownership

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 16.6% of Movano shares are held by institutional investors. 25.2% of Bullfrog AI shares are held by insiders. Comparatively, 21.1% of Movano shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Bullfrog AI and Movano”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$60,000.00	186.21	-$6.99 million	($0.76)	-1.43
Movano	$1.01 million	4.27	-$23.73 million	($40.69)	-0.13

Bullfrog AI has higher earnings, but lower revenue than Movano. Bullfrog AI is trading at a lower price-to-earnings ratio than Movano, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bullfrog AI and Movano’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-195.35%	-162.37%
Movano	-4,302.13%	-359.83%	-203.15%

Analyst Recommendations

This is a summary of recent recommendations and price targets for Bullfrog AI and Movano, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1	0	0	0	1.00
Movano	1	0	0	0	1.00

Volatility and Risk

Bullfrog AI has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, Movano has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Summary

Bullfrog AI beats Movano on 7 of the 11 factors compared between the two stocks.

About Bullfrog AI

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

About Movano

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.